Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi.

Kumar H, Belperron A, Barthold SW, Bockenstedt LK.

J Immunol. 2000 Nov 1;165(9):4797-801.

2.
3.

Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.

Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ.

J Immunol. 2002 Jan 1;168(1):348-55.

4.

Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.

Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.

J Immunol. 2001 Jun 15;166(12):7398-403.

5.
6.

T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.

Keane-Myers A, Nickell SP.

J Immunol. 1995 Feb 15;154(4):1770-6.

PMID:
7836761
7.

Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A.

Golde WT, Kappel KJ, Dequesne G, Feron C, Plainchamp D, Capiau C, Lobet Y.

Infect Immun. 1994 Jun;62(6):2625-7. Erratum in: Infect Immun 1995 Mar;63(3):1146.

9.

Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis.

Busch DH, Jassoy C, Brinckmann U, Girschick H, Huppertz HI.

J Immunol. 1996 Oct 15;157(8):3534-41.

PMID:
8871653
10.

Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.

Bockenstedt LK, Fikrig E, Barthold SW, Kantor FS, Flavell RA.

J Immunol. 1993 Jul 15;151(2):900-6.

PMID:
8335917
14.

Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens.

de Souza MS, Fikrig E, Smith AL, Flavell RA, Barthold SW.

J Infect Dis. 1992 Mar;165(3):471-8.

PMID:
1531672
16.
17.

Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.

Bockenstedt LK, Fikrig E, Barthold SW, Flavell RA, Kantor FS.

J Immunol. 1996 Dec 15;157(12):5496-502.

PMID:
8955199
18.

Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.

Keane-Myers A, Nickell SP.

J Immunol. 1995 Aug 15;155(4):2020-8.

PMID:
7636253
19.

Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.

Lovrich SD, Jobe DA, Schell RF, Callister SM.

Clin Diagn Lab Immunol. 2005 Jun;12(6):746-51. Erratum in: Clin Diagn Lab Immunol. 2005 Sep;12(9):1139.

20.

OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant.

Erdile LF, Guy B.

Vaccine. 1997 Jun;15(9):988-96.

PMID:
9261945

Supplemental Content

Support Center